Phase I trial of AEG35156 administered as a 7-day and 3-day continuous intravenous infusion in patients with advanced refractory cancer (Q33383417)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I trial of AEG35156 administered as a 7-day and 3-day continuous intravenous infusion in patients with advanced refractory cancer |
scientific article |
Statements
1 reference
Phase I trial of AEG35156 administered as a 7-day and 3-day continuous intravenous infusion in patients with advanced refractory cancer (English)
1 reference
Malcolm Ranson
1 reference
Jeff Cummings
1 reference
Duncan Jodrell
1 reference
Kate Connolly
1 reference
Sarah Danson
1 reference
Jacques Jolivet
1 reference
Jon Durkin
1 reference
Stephen Morris
1 reference
Debra Jowle
1 reference
Tim Ward
1 reference
Gemma Dickinson
1 reference
Leon Aarons
1 reference
Eric Lacasse
1 reference
Lesley Robson
1 reference
23 February 2009
1 reference
1 reference
Identifiers
1 reference